- Fluorescence in situ hybridization confirmation of 5q deletions in patients with hematological malignancies2000 | Publication without faculty affiliation
- Analyse of 5q deletions in myeloid malignancies by mBAND and mFISHPublication without faculty affiliation
- Deletion of the long arm but not the 5q31 region of chromosome 5 in myeloid malignancies2012 | First Faculty of Medicine
- Multicolor banding fluorescence in situ hybridization technique in the evaluation of 5q deletionsPublication without faculty affiliation
- Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion2018 | Publication without faculty affiliation
- Combination of molecular cytogenetic techniques in mapping of the atypical 5q deletion in myeloid malignanciesPublication without faculty affiliation
- Analysis of 5q deletions in myeloid malignancies by high resolution multicolor banding (mBAND)Publication without faculty affiliation
- Multicolor bandig fluorescence in situ hybridization (mBAND) technique in the evaluation of 5q deletionsPublication without faculty affiliation
- Lenalidomide treatment in myelodysplastic syndrome with 5q deletion - Czech MDS group experience2015 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- High level of full-length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide2015 | Faculty of Science
- True monosomy of chromosome 5 is presumably not an isolated cytogenetic entity in MDSPublication without faculty affiliation
- Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents2016 | First Faculty of Medicine
- Early Diagnosis of the Chromosomal Deletion 5q14.2-q21.3 in a Preterm Newborn: Case Report2013 | First Faculty of Medicine
- Lenalidomide treatment of patients with 5q- syndrome affects genes located in the TNF pathwayPublication without faculty affiliation
- Differential Expression of MicroRNAs in CD34+ Cells of 5q- Syndrome2011 | First Faculty of Medicine
- Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q-MDS (IPSS low and intermediate-1)2012 | Publication without faculty affiliation